C. Stratton

Hypoalbuminaemia as a Prognostic Biomarker of First-Line Treatment Resistance in Metastatic Non-small Cell Lung Cancer

M. Stares, J. Leach, I. Phillips, 2021, Frontiers in Nutrition.

Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer

M. Stares, K. Cumming, I. Phillips, 2022, ESMO open.